3 December 2019

When initiating a sub-biobank, clear information must be available for potential participants, with several essential components. The Radboud Biobank has drafted a template for the Information letter and consent form. This template is used as a standard for review by the CMO Radboudumc/CMO-light. This template is to be used as a guide for both the structure and the wording in the information letter. The template has been created under the advisement of the Patient Advisory Board (PAR), the communication department and the CMO-light.
 
  • Want to know more about these subjects? Click on the buttons below for more news.

    Radboud Biobank

Related news items


Biobank information for patients on the Radboudumc website

3 December 2019

There is patient information available about biobanking in Dutch.

read more

Nijmegen Bladder Cancer Study (NBCS)

3 December 2019

The aim of NBCS is to investigate lifestyle factors and genetic factors in relation to the risk of bladder cancer, the course of the disease, and the effect of therapy.

read more

FUTURE Biobank

3 December 2019

The “Follow-Up of Transient ischemic attack and stroke patients and Unelucidated Risk factor Evaluation” (FUTURE) study is a prospective cohort study of prognosis of stroke in young adults.

read more

Nijmegen Four Day March Cohort

3 December 2019

Participants in the Nijmegen Four Days Marches are asked annually to complete an online questionnaire.

read more

AortaBank

3 December 2019

The ambition of AortaBank is to store biomaterial and associated clinical data of all patients who undergo operations on the Aorta(valve).

read more

Visibility of the Radboud Biobank

17 October 2019

It is essential to have a complete and up-to-date list of publications where the Radboud Biobank has provided source material and data.

read more